Clinical Trials in Miami

Showing 6521-6540 of 11,431 trials

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

NCT04089761

Nerivio™ is an FDA-authorized remote electrical neuromodulation (REN) device for the acute treatment of migraine with or without aura in patients 18 years old or above who do not have chronic migraine. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. This is a prospective, single arm, open label, multicenter trial of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescents The study will be conducted in three phases: Phase I - Run-in: Phase II - Treatment phase: Phase III (optional) - Free-use

Acute Migraine

Theranica60 participantsStarted Oct 2019

Aurora, Colorado, United States • Hialeah, Florida, United States • Miami, Florida, United States +9 more locations

COMPLETEDPhase 1< 1 mile

Study of Single-dose DS-3201b in Participants With Hepatic Impairment

NCT04276662

This is a Phase 1, open-label, parallel design, single-dose pharmacokinetic (PK) study to assess the safety, tolerability, and PK of a single dose of 50 mg of DS-3201b in participants with normal and impaired hepatic function.

Hepatic Impairment

Daiichi Sankyo28 participantsStarted Nov 2019

Miami, Florida, United States • Orlando, Florida, United States • San Antonio, Texas, United States

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Study of Single-dose DS-3201b in Participants With Hepatic Impairment

Find Trials by Condition in Miami

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Hemodialysis Access Surveillance Evaluation Study

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Femoral Artery Crossover Rates in 1000 Consecutive Radial Cath Labs Procedures.

A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury

Phase 3 Papulopustular Rosacea Study

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Epiduo Pediatric Acne Study

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Celebrex In Acute Gouty Arthritis Study

Atorvastatin Three Year Pediatric Study

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Self-directed Video Versus Instructor-based Neonatal Resuscitation Training